Anaptysbio Inc (ANAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Sales | 970 | 1,011 | 20,890 | 30,027 | 11,247 |
| Gross Profit | 970 | 1,011 | 20,890 | 30,027 | 11,247 |
| Operating Expenses | 32,719 | 32,168 | 27,653 | 30,560 | 29,608 |
| Operating Income | -31,749 | -31,157 | -6,763 | -533 | -18,361 |
| Other Income | -4,506 | -1,381 | 97 | 104 | 198 |
| Pre-tax Income | -36,255 | -32,538 | -6,666 | -429 | -18,163 |
| Net Income Continuous | -36,255 | -32,538 | -6,666 | -429 | -18,163 |
| Net Income | $-36,255 | $-32,538 | $-6,666 | $-429 | $-18,163 |
| EPS Basic Total Ops | -1.31 | -1.19 | -0.24 | -0.02 | -0.66 |
| EPS Basic Continuous Ops | -1.31 | -1.18 | -0.24 | -0.02 | -0.66 |
| EPS Diluted Total Ops | -1.31 | -1.19 | -0.24 | -0.02 | -0.66 |
| EPS Diluted Continuous Ops | -1.31 | -1.18 | -0.24 | -0.02 | -0.66 |
| EBITDA(a) | $-31,015 | $-30,672 | $-5,994 | $378 | $-17,943 |